Where does Bio-medical Engineering (HK) Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bio-medical Engineering (HK) Limited ranks #8,337 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bio-medical Engineering (HK) Limited hold?

Bio-medical Engineering (HK) Limited holds 38 US utility patents granted between 2015 and 2023, spanning 11 technology areas.

What is Bio-medical Engineering (HK) Limited's Innovation Score?

Bio-medical Engineering (HK) Limited has an Innovation Score of 38.7 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bio-medical Engineering (HK) Limited focus on?

Bio-medical Engineering (HK) Limited's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 38 patents, ranking #502 of 7,127 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Bio-medical Engineering (HK) Limited's patent grant rate increasing or decreasing?

Bio-medical Engineering (HK) Limited's recent grant velocity is +11% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Bio-medical Engineering (HK) Limited's patents?

Bio-medical Engineering (HK) Limited's patents average 21.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bio-medical Engineering (HK) Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bio-medical Engineering (HK) Limited

USPTO PatentsView assignee record - 38 granted patents across 11 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bio-medical ranks #8,337 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 11 technology areas.

#8,337
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.7/100): 21.8
avg claims per patent: +11%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8337 · Foreign Corporation #8,337 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,337/49,997
PHOTO-FINISH Apotex
CPC-FOCUS A61B · 11 areas
INNOV-THIN 38.7/100
CLAIMS-DENSE 21.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +11% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Apotex Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bio-medical’s 38.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (33%) Velocity 1.2 pts (3%) Breadth 11.7 pts (30%) Claim depth 13.1 pts (34%)

Qualcomm Incorporated · highest

85
Bio-medical… · this assignee

39
Data I/O · near

39
Elite Semiconductor… · near

39
GE Oil & Gas ESP · near

39
Lexington Medical · near

39
3D Lighting… · lowest

7

What this shows Bio-medical's Innovation Score is 38.7/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bio-medical?

Each dot is one of Bio-medical’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bio-medical’s own 21.8 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bio-medical vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bio-medical's grants concentrate

Bio-medical Engineering (HK) Limited is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (9 grants) versus a trough of 1 in 2015. By volume, Bio-medical sits between Apotex Inc. and Battenfeld Technologies, Inc..

Bio-medical's three-year grant acceleration

From 2019–2021 to 2022–2024, Bio-medical Engineering (HK) Limited moved from 22 to 4 grants (0.18x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Apotex

38
Aqua-leisure Indu…

38
Aurea Software

38
Banner Life Scien…

38
BOE (Hebei) Mobil…

38
Bosch Mahle Turbo…

38
Bway

38
Battenfeld

38
Bio-medical Engin… ◀

38

What this shows Bio-medical holds 38 patents at rank #8,334, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bio-medical

By rank, the assignees closest to #8,334 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Bio-medical's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bio-medical, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Bio-medical ranks #502 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

GE Oil & Gas ESP, Inc. 39 Data I/O Corporation 39 Elite Semiconductor Memory Technology Inc. 39 Lexington Medical, Inc. 39

Bio-medical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bio-medical Engineering (HK) Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.6%
2017	4	10.5%
2018	7	18.4%
2019	6	15.8%
2020	7	18.4%
2021	9	23.7%
2022	1	2.6%
2023	3	7.9%

Which technologies does Bio-medical Engineering (HK) Limited patent most?

A61B - DIAGNOSIS; SURGERY; Identification 38

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 22

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

Y10T - Technical Subjects Covered BY Former US Classification 4

F16H - Gearing 3

G06V - Image OR Video Recognition OR Understanding 1

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

G06T - Image Data Processing OR Generation, IN General 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bio-medical Engineering (HK) Limited's patent record in context - here's where to go next.

Bio-medical Engineering (HK) Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #8,337 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bio-medical Engineering (HK) Limited against Apotex Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.